APA

Sadushi-Kolici R., Jansa P., Kopec G., Torbicki A., Skoro-Sajer N., Campean I., Halank M., Simkova I., Karlocai K., Steringer-Mascherbauer R., Samarzija M., Salobir B., Klepetko W., Lindner J. & Lang I. M. (20200415). Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. : The Lancet. Respiratory medicine.

Chicago

Sadushi-Kolici Roela, Jansa Pavel, Kopec Grzegorz, Torbicki Adam, Skoro-Sajer Nika, Campean Ioana-Alexandra, Halank Michael, Simkova Iveta, Karlocai Kristof, Steringer-Mascherbauer Regina, Samarzija Miroslav, Salobir Barbara, Klepetko Walter, Lindner Jaroslav and Lang Irene M. 20200415. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. : The Lancet. Respiratory medicine.

Harvard

Sadushi-Kolici R., Jansa P., Kopec G., Torbicki A., Skoro-Sajer N., Campean I., Halank M., Simkova I., Karlocai K., Steringer-Mascherbauer R., Samarzija M., Salobir B., Klepetko W., Lindner J. and Lang I. M. (20200415). Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. : The Lancet. Respiratory medicine.

MLA

Sadushi-Kolici Roela, Jansa Pavel, Kopec Grzegorz, Torbicki Adam, Skoro-Sajer Nika, Campean Ioana-Alexandra, Halank Michael, Simkova Iveta, Karlocai Kristof, Steringer-Mascherbauer Regina, Samarzija Miroslav, Salobir Barbara, Klepetko Walter, Lindner Jaroslav and Lang Irene M. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. : The Lancet. Respiratory medicine. 20200415.